PMC:7029759 / 11579-11746 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"265","span":{"begin":22,"end":31},"obj":"Species"}],"attributes":[{"id":"A265","pred":"tao:has_database_id","subj":"265","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ideal agents to fight 2019-nCoV would be approved small molecule drugs that could inhibit different aspects of the viral life cycle, ultimately inhibiting replication."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T218","span":{"begin":6,"end":12},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T217","span":{"begin":22,"end":31},"obj":"SP_7"},{"id":"T216","span":{"begin":56,"end":64},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T215","span":{"begin":65,"end":70},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T214","span":{"begin":115,"end":120},"obj":"NCBITaxon:10239"},{"id":"T213","span":{"begin":121,"end":125},"obj":"UBERON:0000104"},{"id":"T212","span":{"begin":155,"end":166},"obj":"GO:0006260"}],"text":"Ideal agents to fight 2019-nCoV would be approved small molecule drugs that could inhibit different aspects of the viral life cycle, ultimately inhibiting replication."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T32","span":{"begin":56,"end":64},"obj":"Chemical"},{"id":"T33","span":{"begin":65,"end":70},"obj":"Chemical"}],"attributes":[{"id":"A32","pred":"chebi_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Ideal agents to fight 2019-nCoV would be approved small molecule drugs that could inhibit different aspects of the viral life cycle, ultimately inhibiting replication."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T6","span":{"begin":115,"end":131},"obj":"http://purl.obolibrary.org/obo/GO_0019058"}],"text":"Ideal agents to fight 2019-nCoV would be approved small molecule drugs that could inhibit different aspects of the viral life cycle, ultimately inhibiting replication."}

{"project":"LitCovid-sentences","denotations":[{"id":"T73","span":{"begin":0,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ideal agents to fight 2019-nCoV would be approved small molecule drugs that could inhibit different aspects of the viral life cycle, ultimately inhibiting replication."}